The Canadian Centre for Ethics in Sport (CCES) announced today that David Freake, an athletics athlete, received a four-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on May 26, 2019, revealed the presence of GW501516, 2-4-dinitrophenol and recombinant EPO, all prohibited substances, and ephedrine, a specified substance.

In response to the CCES’s notification of the adverse analytical finding, Mr. Freake waived his right to a hearing and accepted the proposed sanction, which terminates on October 10, 2023. During the sanction period, the athlete, who resides in St. John’s, NL, is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates. In compliance with rule 7.10 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.

• This media release was published by the Canadian Centre for Ethics in Sport (CCES) on 22 October 2019. Click here for the original.